Plain-English translation of NCT07335510 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether the Barostim™ device can help people with advanced heart failure (where the heart's pumping power is significantly reduced) feel better and live better lives. The device is implanted under the skin and gently stimulates a nerve in your neck that helps control how your heart and blood vessels work. Researchers want to understand how this treatment affects the heart's function and your ability to exercise.
Many people with severe heart failure continue to struggle with symptoms and have difficulty exercising, even when taking the strongest available medications. This new treatment targets the nervous system in a different way than current medicines do, offering hope for patients who still feel sick despite being on maximum medical therapy.
You likely qualify if…
You likely don't qualify if…
You would undergo a surgical procedure to implant the Barostim device under your skin, similar to getting a pacemaker. After implantation, you would return to the clinic for device programming and adjustments over the next three months. You would also undergo heart testing (including a procedure where a small tube is placed in your heart to measure how well it's pumping) and exercise testing to see how the device helps you.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States